ArticleFrontiers in cardiovascular medicine2026
Association between lesion-specific fat attenuation index and high-risk plaque on coronary computed tomography angiography.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate the association between lesion-specific fat attenuation index (FAI) derived from coronary computed tomography angiography (CCTA) and CCTA-defined high-risk plaque (HRP). Methods: A total of 560 patients undergoing CCTA for the first time who had at least one evaluable coronary atherosclerotic lesion were consecutively included. One target lesion was selected for each patient. Four CCTA-derived high-risk plaque features were assessed, including low-attenuation plaque, positive remodeling, spotty calcification, and the napkin-ring sign. Lesions exhibiting at least two of these features were classified as CCTA-defined HRP, and lesion-specific FAI was quantified from the pericoronary adipose tissue surrounding the target lesion and expressed in Hounsfield units (HU). Binary logistic regression was used to evaluate the association between lesion-specific FAI and CCTA-defined HRP. Restricted cubic spline analysis was performed to characterize the shape of the association, and subgroup and sensitivity analyses were conducted to evaluate the robustness of the findings. Results: Lesion-specific FAI was significantly higher in patients with CCTA-defined HRP than in those without HRP (-76.5 ± 4.8 HU vs. -81.0 ± 4.8 HU), with a mean difference of 4.47 HU [95% confidence interval (CI), 3.54-5.41 HU, Conclusions: Higher lesion-specific FAI was independently associated with CCTA-defined HRP, with higher odds of HRP across increasing FAI values. The association remained consistent across subgroup and sensitivity analyses. Lesion-specific FAI may provide complementary information for characterizing CCTA-defined high-risk plaque and assessing the local perilesional environment. Further prospective studies with invasive imaging or longitudinal clinical outcomes are needed to determine its potential incremental value.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.